SE448945B - Forfarande for rening och /eller koncentrering av faktor viii-komplexet - Google Patents

Forfarande for rening och /eller koncentrering av faktor viii-komplexet

Info

Publication number
SE448945B
SE448945B SE7910527A SE7910527A SE448945B SE 448945 B SE448945 B SE 448945B SE 7910527 A SE7910527 A SE 7910527A SE 7910527 A SE7910527 A SE 7910527A SE 448945 B SE448945 B SE 448945B
Authority
SE
Sweden
Prior art keywords
factor viii
solution
glycine
precipitate
complex
Prior art date
Application number
SE7910527A
Other languages
English (en)
Swedish (sv)
Other versions
SE7910527L (sv
Inventor
Erik Gustaf Birger Blombeck
Lars Gunnar Thorell
Original Assignee
Blombaeck E G B
Lars Gunnar Thorell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20339607&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE448945(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Blombaeck E G B, Lars Gunnar Thorell filed Critical Blombaeck E G B
Priority to SE7910527A priority Critical patent/SE448945B/sv
Priority to US06/215,530 priority patent/US4348315A/en
Priority to EP80850193A priority patent/EP0032655B2/de
Priority to AT80850193T priority patent/ATE3045T1/de
Priority to DE8080850193T priority patent/DE3062792D1/de
Publication of SE7910527L publication Critical patent/SE7910527L/xx
Publication of SE448945B publication Critical patent/SE448945B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE7910527A 1979-12-20 1979-12-20 Forfarande for rening och /eller koncentrering av faktor viii-komplexet SE448945B (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE7910527A SE448945B (sv) 1979-12-20 1979-12-20 Forfarande for rening och /eller koncentrering av faktor viii-komplexet
US06/215,530 US4348315A (en) 1979-12-20 1980-12-11 Process in purification and concentration of the factor VIII-complex
EP80850193A EP0032655B2 (de) 1979-12-20 1980-12-18 Verfahren zur Reinigung und Konzentrierung des Faktor-VIII-Komplexes
AT80850193T ATE3045T1 (de) 1979-12-20 1980-12-18 Verfahren zur reinigung und konzentrierung des faktor-viii-komplexes.
DE8080850193T DE3062792D1 (en) 1979-12-20 1980-12-18 A process in purification and concentration of the factor viii-complex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7910527A SE448945B (sv) 1979-12-20 1979-12-20 Forfarande for rening och /eller koncentrering av faktor viii-komplexet

Publications (2)

Publication Number Publication Date
SE7910527L SE7910527L (sv) 1981-06-21
SE448945B true SE448945B (sv) 1987-03-30

Family

ID=20339607

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7910527A SE448945B (sv) 1979-12-20 1979-12-20 Forfarande for rening och /eller koncentrering av faktor viii-komplexet

Country Status (5)

Country Link
US (1) US4348315A (de)
EP (1) EP0032655B2 (de)
AT (1) ATE3045T1 (de)
DE (1) DE3062792D1 (de)
SE (1) SE448945B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
EP0148843B2 (de) * 1983-03-21 1994-05-04 Novo Nordisk A/S Antihämophilie-faktor-viii-konzentrat und dessen herstellungsverfahren
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4670394A (en) * 1984-11-16 1987-06-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
DE3926034C3 (de) * 1989-08-07 1996-11-21 Behringwerke Ag Verfahren zur Herstellung eines stabilen Faktors VIII
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
CA1101332A (fr) * 1976-01-30 1981-05-19 Edward Shanbrom Procedes simplifies pour la preparation de concentres de facteur viii de tres grande purete
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma

Also Published As

Publication number Publication date
EP0032655B1 (de) 1983-04-13
DE3062792D1 (en) 1983-05-19
US4348315A (en) 1982-09-07
ATE3045T1 (de) 1983-04-15
SE7910527L (sv) 1981-06-21
EP0032655A1 (de) 1981-07-29
EP0032655B2 (de) 1986-08-20

Similar Documents

Publication Publication Date Title
SE448945B (sv) Forfarande for rening och /eller koncentrering av faktor viii-komplexet
DE69333928T2 (de) Verbesserte solubilisierung und stabilisierung des faktor viii-komplexes
DE69333724T2 (de) Hybrider menschlich-schweinlicher faktor viii
DE69735295T2 (de) Verfahren zur Aufkonzentrierung von Antikörperlösungen
Patek et al. Hemophilia. II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood
EP0329605B1 (de) Verfahren zur Herstellung von Apolipoproteinen aus Blutplasma- oder Serumfraktionen
AT516600B1 (de) Herstellung von faktor h (fh) und fh-derivaten aus plasma
EP0383234B1 (de) Pasteurisiertes, gereinigtes von Willebrand-Faktor-Konzentrat und Verfahren zu seiner Herstellung
DE2029455C3 (de) Verfahren zur Herstellung eines neuen Prothrombinkomplexes
CA1074698A (en) Method of collecting anti-hemophilic factor viii from blood and blood plasma
CN109180776A (zh) 通过用微细分的二氧化硅处理去除丝氨酸蛋白酶
JP2011184454A (ja) 液状形態及び凍結乾燥形態の免疫グロブリンｇ組成物用安定化配合物
Dike et al. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate containing factor VII
FI72653B (fi) Foerfarande foer framstaellning av ett faktor viii(ahf)-koncentrat.
CN103153333B (zh) 补体因子h的纯化方法
CN103945862A (zh) 使蛋白质稳定的制剂
EP0106269A2 (de) Verfahren zur Pasteurisierung von antihämophilem Kryopräzipitat (AHK) und danach hergestelltes antihämophiles Kryopräzipitat
EP0906340B1 (de) Reinigung von faktor viii-komplex durch immunaffinitätschromatographie
US3904751A (en) Process for isolating a fibrin stabilizing factor from human placenta
CA1293941C (en) Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product
EP1405863B1 (de) Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
EP0052874A1 (de) Verfahren zum Erzeugen der Vorgerinnungsaktivität des Faktors VIII
Middleton Polyelectrolytes and preparation of factor VIIIC
JPS6242887B2 (de)
Holmberg et al. Factor VIII: C and VIII: CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7910527-6

Effective date: 19890301

Format of ref document f/p: F